A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides

Dermatologic Surgery

Volumn 33, Issue 4, 2007, Pages 461-468

  Hantash, Basil M ^a   Gladstone, Hayes B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FACE MUSCLE HYPERACTIVITY; FEMALE; HUMAN; HYPERACTIVITY; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; MALE; MEDICAL ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; PTOSIS; PURPURA; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SAMPLE SIZE; SCORING SYSTEM; SINGLE BLIND PROCEDURE; THERAPY EFFECT; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

ADRENERGIC AGONISTS; ADULT; BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; DOUBLE-BLIND METHOD; EPINEPHRINE; FACIAL MUSCLES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE RELAXATION; NEUROMUSCULAR AGENTS; ORBIT; PATIENT SATISFACTION; SKIN AGING;

EID: 34147166089     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.33094.x     Document Type: Article

References (14)

1. 2005 cosmetic surgery national data bank: statistics [monograph on the Internet]. New York: American Society for Aesthetic Plastic Surgery; c2005. Available from: http://www.surgery.org/download/2005stats.pdf
2. Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Opthalmol 1973;12:924-7.
3. Binder W, Brin MF, Blitzer A, et al. Botulinum toxin type A (BTX-A) for migraine: an open label asssessment [abstract]. Mov Disord 1998;13:241a.
4. Carruthers A, Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg 2001;20:71-84.
5. BOTOX Cosmetic prescribing information [monograph on the Internet]. Irvine (CA): Allergan Inc.; c2006. Available from: http://www.botoxcosmetic.com/ resources/pi.aspx
6. Covino BG. Local anesthesia. 1. N Engl J Med 1972;286:975-83.
7. Covino BG. Local anesthesia. 2. N Engl J Med 1972;286:1035-42.
8. Wilhelmi BJ, Blackwell SJ, Miller JH, et al. Do not use epinephrine in digital blocks: myth or truth. Plast Reconstr Surg 2001;107:393-7.
9. Polley LS, Columb MO, Naughton NN, et al. Effect of epidural epinephrine on the minimum local analgesic concentration of epidural bupivicaine in labor. Anesthesiology 2002;96:1123-8.
10. Alam M, Dover JS, Arndt K. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial. Arch Dermatol 2002;138:510-4.
11. Coté TR, Mohan AK, Polder JA, et al. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 2005;53:407-15.
12. Redaelli A, Forte R. Botulinum toxin dilution: our technique. J Cosmet Laser Ther 2003;5:218-9.
13. Gassner HG, Sherris DA. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin A injections: a randomized controlled study. Mayo Clin Proc 2000;75:701-4.
14. Flynn TC, Carruthers JA, Carruthers JA, et al. Botulinum A toxin (Botox) in the lower eyelid: dose-finding study. Dermatol Surg 2003;29:943-51.